These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25348521)

  • 21. Deoxycytidine deaminase-deficient Escherichia coli strains display acute sensitivity to cytidine, adenosine, and guanosine and increased sensitivity to a range of antibiotics, including vancomycin.
    Kang TM; Yuan J; Zhou A; Beppler C; Miller JH
    J Bacteriol; 2014 Jun; 196(11):1950-7. PubMed ID: 24633874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The antimicrobial activity of mecillinam, nitrofurantoin, temocillin and fosfomycin and comparative analysis of resistance patterns in a nationwide collection of ESBL-producing Escherichia coli in Norway 2010-2011.
    Zykov IN; Sundsfjord A; Småbrekke L; Samuelsen Ø
    Infect Dis (Lond); 2016 Feb; 48(2):99-107. PubMed ID: 26414659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High frequency of co-resistance in CTX-M-producing Escherichia coli to non-beta-lactam antibiotics, with the exceptions of amikacin, nitrofurantoin, colistin, tigecycline, and fosfomycin, in a county of Sweden.
    Östholm Balkhed Å; Tärnberg M; Monstein HJ; Hällgren A; Hanberger H; Nilsson LE
    Scand J Infect Dis; 2013 Apr; 45(4):271-8. PubMed ID: 23113731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitivity of enterococci to beta-lactam antibiotics, co-trimoxazole, nitrofurantoin, tetracycline and doxycycline.
    Grimm H
    Arzneimittelforschung; 1983; 33(3):419-23. PubMed ID: 6603227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
    Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
    J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Encapsulation in fusogenic liposomes broadens the spectrum of action of vancomycin against Gram-negative bacteria.
    Nicolosi D; Scalia M; Nicolosi VM; Pignatello R
    Int J Antimicrob Agents; 2010 Jun; 35(6):553-8. PubMed ID: 20219328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole.
    Murray BE; Rensimer ER; DuPont HL
    N Engl J Med; 1982 Jan; 306(3):130-5. PubMed ID: 7033781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative antibacterial activity of fleroxacin: selection frequencies and outer membrane proteins of resistant mutants].
    Cullmann W; Dechène M; Stieglitz M
    Immun Infekt; 1988 Aug; 16(4):152-8. PubMed ID: 3141267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of R-plasmid-determined resistance to aminoglycoside antibiotics by R-plasmid nitrofurantoin resistance in Escherichia coli.
    Obaseiki-Ebor EE; Gborikoko C
    Chemotherapy; 1984; 30(2):92-6. PubMed ID: 6365482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potent antibacterial nanoparticles for pathogenic bacteria.
    Lai HZ; Chen WY; Wu CY; Chen YC
    ACS Appl Mater Interfaces; 2015 Jan; 7(3):2046-54. PubMed ID: 25584802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ten years surveillance of antimicrobial susceptibility of community-acquired Escherichia coli and other uropathogens in northern Israel (1995-2005).
    Rock W; Colodner R; Chazan B; Elias M; Raz R
    Isr Med Assoc J; 2007 Nov; 9(11):803-5. PubMed ID: 18085038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
    Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
    Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A mutant Escherichia coli that attaches peptidoglycan to lipopolysaccharide and displays cell wall on its surface.
    Grabowicz M; Andres D; Lebar MD; Malojčić G; Kahne D; Silhavy TJ
    Elife; 2014 Dec; 3():e05334. PubMed ID: 25551294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial Susceptibility and SOS-Dependent Increase in Mutation Frequency Are Impacted by Escherichia coli Topoisomerase I C-Terminal Point Mutation.
    Yang J; Annamalai T; Cheng B; Banda S; Tyagi R; Tse-Dinh YC
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6195-202. PubMed ID: 26248366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of trovafloxacin against Bacteroides fragilis in mixed culture with either Escherichia coli or a vancomycin- resistant strain of Enterococcus faecium determined by an anaerobic time-kill technique.
    Stearne LE; Kooi C; Goessens WH; Bakker-Woudenberg IA; Gyssens IC
    Antimicrob Agents Chemother; 2001 Jan; 45(1):243-51. PubMed ID: 11120973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution and transferability of plasmids in trimethoprim resistant urinary Escherichia coli.
    Kraft CA; Platt DJ; Timbury MC
    J Med Microbiol; 1983 Nov; 16(4):433-41. PubMed ID: 6358500
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High genetic diversity of nitrofurantoin- or mecillinam-resistant Escherichia coli indicates low propensity for clonal spread.
    Poulsen HO; Johansson A; Granholm S; Kahlmeter G; Sundqvist M
    J Antimicrob Chemother; 2013 Sep; 68(9):1974-7. PubMed ID: 23640126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations of growth rate and gene expression levels of UPEC by antibiotics at sub-MIC.
    Gümüş D; Kalaycı-Yüksek F; Yörük E; Uz G; Çelik E; Arslan C; Aydın EM; Canlı C; Anğ-Küçüker M
    Folia Microbiol (Praha); 2018 Jul; 63(4):451-457. PubMed ID: 29327292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacterial growth kinetics of Escherichia coli and mycobacteria in the presence of brodimoprim and metioprim alone and in combination with sulfamerazine and dapsone (VI).
    Seydel JK; Wempe EG; Rosenfeld M
    Chemotherapy; 1983; 29(4):249-61. PubMed ID: 6347548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. When less is more: shortening the Lpp protein leads to increased vancomycin resistance in Escherichia coli.
    Wykes H; Le VVH; Olivera C; Rakonjac J
    J Antibiot (Tokyo); 2023 Dec; 76(12):746-750. PubMed ID: 37749219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.